Cancer Research UK UCL Centre Development Fund Award (2019-2020)
Modelling tumour killing by autologous lymphocytes using non-small cell lung cancer organoids. Principal Investigator, Co-PI: Prof. Charles Swanton, The Francis Crick Institute.
UCLH BRC Inflammation, Immunity and Immunotherapeutics Theme (2019-2020)
Establishing a robust scientific rationale for progressing ATP-competitive mTOR inhibitors as a novel anti-fibrotic strategy in idiopathic pulmonary fibrosis. Co-investigator, PI Prof. Rachel Chambers, UCL.
University College London Hospitals (UCLH) BRC Cancer Theme (2018-2020)
A method to accurately deconvolute the tumour immune microenvironment. Collaborator, PIs: Dr. Yin Wu, Mr. Dhruva Biswas, UCL.
Sir Henry Wellcome Postdoctoral Fellowship (Jan 2018 - Dec 2021) “Patient-derived models of heterogeneous non-small cell lung cancer” Cancer Evolution and Genome Instability Laboratory Collaborators: Prof. Charles Swanton, Prof. Sergio Quezada, Prof. Hans Clevers.
Roy Castle Lung Cancer Foundation (Sept 2017 - Sept 2019) "Understanding pre-malignant squamous cell carcinoma cell biology to enable targeted early clinical intervention" Principal Investigator, Co-I Prof. Sam Janes, UCL.
UHU Research Collaborative Seed Funding (Sept 2016 - Sept 2017) "Investigating HGF-induced STAT6 signaling in stromal-epithelial cross-talk" Co-investigator (PIs Prof. Sam Janes, UCL and Dr. Cecilia Prele, University of Western Australia).